The surgeon who operated on an Italian girl, Camilla Canepa, who died at the age of 18 from the effects of the vaccine, said he has never seen anything like this. “It’s not normal,” he added.
Published: June 27, 2021, 1:09 pm
Covid-19 vaccines: Saving three lives while putting two at risk
Camilla Canepa was operated on by Gianluigi Zona, director of the neurosurgical and neuro-traumatological clinic of the San Martino hospital: “I had never seen a brain that was affected by such an extensive and severe thrombosis.”
The neurosurgeon on duty in San Martino that night was Alessandro d’Andrea, who also called the chief physician to his side at the operating table. “We decided to have a decompression craniotomy, in which the skull is opened to relieve internal pressure.”
Zona recounted the experience: “All venous sinuses were blocked with thrombi, a scenario I have never seen in my many years in this profession. Think of the venous sinus as the river in the middle of a valley where several streams converge. If a dam is built in the middle of the watercourse, the river swells and the tributaries can no longer drain at this point, so that the pressure rises upstream.
“I’m neither a virologist, nor an epidemiologist, nor a coroner, but given the image I saw in the girl’s head, it is clear that we are dealing with something that is not normal.”
The parents of the 18-year-old who died, told the media: “She had no disease.” Last week, the prosecutor of Genoa, which coordinates the ongoing investigations, will instruct the Pavia coroner to perform the autopsy on the body of Camilla Canepa, the eighteen year old who died after the vaccine. The girl allegedly suffered from chronic platelet deficiency, a “familial autoimmune thrombocytopenia”. This is what investigators have learned from the first reports of the doctors.
But the girl’s family, assisted by the lawyer Angelo Paone, is firm on this point. “Camilla had no disease,” explained their lawyer. Supporting their claim, are two different CT scans. She had undergone the two scans, and was discharged after the first one that had not shown the situation of the thrombosis in progress, but immediately transferred to the hospital after the second showing that her health had been compromised.
The girl arrived in the emergency room in the Lavagna hospital on June 3, just a week after the AstraZeneca shot. She had complained of severe headaches.
Canepa, who was from the town of Sestri Levante in Liguria, was given the jab during a vaccination “open day” for youths over 18. The AstraZeneca jab has been approved for all over-18s, but in Italy it is only recommended for over-60s due to links to several cases of blood clots in younger people.
Camilla’s case has raised concerns among young people previously keen to get vaccinated to obtain the Green Pass or vaccine passport enabling them to travel and attend mass events.